Pritelivir (Hovilpri) healed all lesions by day 28 in 63% of immunocompromised adults with refractory HSV versus 34% with investigator's choice in the phase 3 PRIOH-1 trial.
|Videos|October 2, 2016
Can a Genital Herpes Vaccine Protect Against Oral Herpes?
Author(s)Contagion Editorial Staff
Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.
Advertisement
Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.
Interview Transcript (slightly modified for readability)
“HSV-1 causes most oral herpes. HSV-1 and HSV-2 are very similar and those two proteins that are in
Advertisement
Related to this article
Lori Handy, MD, provides guidance in these areas, including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
UTI guidelines are moving away from complicated or uncomplicated infections to localized or systemic classification terminologies. Guidelines author Zachary Nelson, PharmD, MPH, BCIDP, provides further insights on the changes including applying antibiograms, potential costs, and whether clinicians will embrace these new classifications.
Demonstrating a diagnostic test works is no longer enough. Clinicians and laboratories also need evidence on how to adopt it in everyday practice. Andrea Prinzi, PhD, MPH, SM(ASCP), explains how implementation science can help infectious disease and clinical microbiology teams turn evidence into routine care.
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Advertisement
Advertisement